Literature DB >> 23089245

Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?

Evelyn Fessler1, Feline E Dijkgraaf, Felipe De Sousa E Melo, Jan Paul Medema.   

Abstract

Stem cells are defined by their self-renewal capacity and the ability to give rise to all differentiated progeny necessary for one specific organ. These two characteristics are also inherent in cancer stem cells (CSCs), which are thought to be the only subpopulation within a tumor endowed with tumorigenic potential. CSCs combine many features that render cancer one of the leading causes of death in the Western world: metastasis, tumor recurrence, and therapy refractoriness. Strikingly, CSCs are not a fixed entity, but differentiated tumor cells are able to revert to a stem-like state. Thus, CSCs are not only intrinsically programmed to fulfill their detrimental roles, but are orchestrated by stromal cells residing in their vicinity and forming the CSC niche. Yet, this relationship is not a one-way road: CSCs are able to manipulate stromal cells to their needs, not only in the primary tumor, but also in distant organs and thus prime the foreign soil for their arrival by inducing a premetastatic niche. The suggested plasticity between the differentiation states of cancer cells and the regulation by microenvironmental cues provides new starting-points for novel cancer therapies.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Metastasis; Microenvironment; Wnt

Mesh:

Year:  2012        PMID: 23089245     DOI: 10.1016/j.canlet.2012.10.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  55 in total

1.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

2.  Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.

Authors:  Donghwi Kim; Mineon Park; Hyunwoong Jang; Hoon Hyun; Wonbong Lim
Journal:  Lasers Med Sci       Date:  2017-09-27       Impact factor: 3.161

Review 3.  Hes1: a key role in stemness, metastasis and multidrug resistance.

Authors:  Zi-Hao Liu; Xiao-Meng Dai; Bin Du
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Non-lethal heat treatment of cells results in reduction of tumor initiation and metastatic potential.

Authors:  Yoo-Shin Kim; Tae Hoon Lee; Brian E O'Neill
Journal:  Biochem Biophys Res Commun       Date:  2015-05-29       Impact factor: 3.575

5.  Mathematical approaches to modeling development and reprogramming.

Authors:  Rob Morris; Ignacio Sancho-Martinez; Tatyana O Sharpee; Juan Carlos Izpisua Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-20       Impact factor: 11.205

6.  Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.

Authors:  Xue-Jing Shao; Sen-Feng Xiang; Ying-Qian Chen; Ning Zhang; Ji Cao; Hong Zhu; Bo Yang; Qian Zhou; Mei-Dan Ying; Qiao-Jun He
Journal:  Acta Pharmacol Sin       Date:  2019-07-11       Impact factor: 6.150

Review 7.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 8.  Metabolism and epigenetics of pancreatic cancer stem cells.

Authors:  M Perusina Lanfranca; J K Thompson; F Bednar; C Halbrook; C Lyssiotis; B Levi; T L Frankel
Journal:  Semin Cancer Biol       Date:  2018-09-28       Impact factor: 15.707

Review 9.  Role of Pericellular Matrix in the Regulation of Cancer Stemness.

Authors:  Sofia Avnet; Margherita Cortini
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

10.  Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.

Authors:  Mohammed Talha Shekhani; Ashika-Sita Jayanthy; Nityanand Maddodi; Vijayasaradhi Setaluri
Journal:  Am J Stem Cells       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.